Business · 08/07/1997

FDA Approves Perclose, Inc.'s Prostar PVS System for Premarket Approval

The US Food and Drug Administration (FDA) has granted premarket approval for Perclose, Inc.'s Prostar Percutaneous Vascular Surgical (PVS) System, a medical device, following a notification from the FDA's Center for Devices and Radiological Health (CDRH) on April 30, 1997.